Sharon Mates, Chairman, President & CEO: Intra-Cellular Therapies ITCI Sell · Filed 23/02/22

Trade details

Type: Insider sale
Amount: $1,065,533.3
Shares · price: 22,895 sh · $46.54 a share
Held after: 1,105,262 sh
Stock: Intra-Cellular Therapies ITCI
Person: Sharon MatesChairman, President & CEO
Trade date: 23/02/21
Filed: 23/02/22
Days to filing: 1 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/01/22~23/03/23

Sharon Mates's recent trades

Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$4.2M
50,163 sh
$4.2M
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.4M
27,667 sh
$2.4M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2M
23,333 sh
$2M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$129.9K
1,534 sh
$129.9K
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.2M
29,832 sh
$2.2M
Filed 24/08/30
Traded 24/08/29

Sharon Mates, Chairman — sold $1.1M of Intra-Cellular Therapies ITCI · 2.0% of holdings | Whalegun